Circulating ELAFIN Is Associated with a Distinct Renal–Inflammatory Phenotype in Type 2 Diabetes Mellitus
Background: ELAFIN (peptidase inhibitor 3, PI3) is an endogenous inhibitor of neutrophil elastase and proteinase 3, but its circulating profile in type 2 diabetes mellitus (T2DM) and cardiovascular disease remains poorly characterized. We investigated circulating ELAFIN in patients undergoing elective coronary angiogra...